Literature DB >> 28540693

Crohn's disease with anorectal stenosis successfully treated with vedolizumab.

Darja Urlep1, Rok Orel2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28540693     DOI: 10.1007/s12519-017-0038-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


× No keyword cloud information.
  6 in total

1.  Clinical Practice Guideline for the Surgical Management of Crohn's Disease.

Authors:  Scott Strong; Scott R Steele; Marylise Boutrous; Liliana Bordineau; Jonathan Chun; David B Stewart; Jon Vogel; Janice F Rafferty
Journal:  Dis Colon Rectum       Date:  2015-11       Impact factor: 4.585

2.  Anorectal stricture in 102 patients with Crohn's disease: natural history in the era of biologics.

Authors:  C Brochard; L Siproudhis; T Wallenhorst; D Cuen; P N d'Halluin; A Garros; J-F Bretagne; G Bouguen
Journal:  Aliment Pharmacol Ther       Date:  2014-08-11       Impact factor: 8.171

Review 3.  Introducing vedolizumab to clinical practice: who, when, and how?

Authors:  R V Bryant; W J Sandborn; S P L Travis
Journal:  J Crohns Colitis       Date:  2015-02-16       Impact factor: 9.071

4.  Perianal Crohn disease: predictors of need for permanent diversion.

Authors:  Susan Galandiuk; Jennifer Kimberling; Talib G Al-Mishlab; Arnold J Stromberg
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

5.  Vedolizumab as induction and maintenance therapy for Crohn's disease.

Authors:  William J Sandborn; Brian G Feagan; Paul Rutgeerts; Stephen Hanauer; Jean-Frédéric Colombel; Bruce E Sands; Milan Lukas; Richard N Fedorak; Scott Lee; Brian Bressler; Irving Fox; Maria Rosario; Serap Sankoh; Jing Xu; Kristin Stephens; Catherine Milch; Asit Parikh
Journal:  N Engl J Med       Date:  2013-08-22       Impact factor: 91.245

Review 6.  Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease.

Authors:  S Singh; N S Ding; K L Mathis; P S Dulai; A M Farrell; J H Pemberton; A L Hart; W J Sandborn; E V Loftus
Journal:  Aliment Pharmacol Ther       Date:  2015-08-11       Impact factor: 8.171

  6 in total
  1 in total

Review 1.  Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy.

Authors:  Yifei Wang; Bin Huang; Tao Jin; Dickson Kofi Wiredu Ocansey; Jiajia Jiang; Fei Mao
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.